Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-31

FDA Approved: ARGATROBAN — Original Application (Mullan Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved a generic version of argatroban from Mullan Pharmaceutical Inc. for anticoagulation in patients with heparin-induced thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Argatroban (argatroban)

Snippet

ORIG AP for ARGATROBAN (ARGATROBAN)